Reaction

Fusarium Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 675 reports · 60 co-occurring drugs

As of the last recalculation, Fusarium Infection appears in 675 FAERS reports alongside 60 co-occurring drug terms. The strongest observed disproportionality signal is POSACONAZOLE DELAYED-RELEASE (PRR 337.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Posaconazole Delayed-Release	102	337.2	340.4
Posaconazole	115	262.8	264.7
Voriconazole Injection	142	255.1	256.8
Amphotericin B	89	252.2	254.0
Voriconazole	151	197.2	198.2
Micafungin Sodium	34	130.2	130.7
Fludarabine Phosphate	121	115.4	115.7
Ganciclovir Sodium	30	91.4	91.7
Cytarabine	133	84.8	84.9
Ganciclovir	24	74.9	75.1
Terbinafine Hydrochloride	20	71.5	71.7
Basiliximab	24	65.2	65.3
Blinatumomab	21	64.0	64.2
Daptomycin	18	61.8	61.9
Meropenem	56	58.6	58.7
Pegaspargase	20	51.9	52.0
Mesna Injection	13	49.4	49.5
Mesna	13	48.5	48.6
Thiotepa	14	46.1	46.2
Valganciclovir	27	46.0	46.0
Valganciclovir Hydrochloride	27	46.0	46.0
Itraconazole	16	43.2	43.3
Alemtuzumab	26	43.1	43.1
Sirolimus	17	39.9	39.9
Atovaquone	10	38.9	38.9
Valganciclovir Hydrochloride Powder,	15	38.8	38.8
Piperacillin And Tazobactam	15	37.0	37.0
Busulfan	18	36.2	36.3
Tacrolimus Ointment 0.1%	120	35.9	36.0
Tacrolimus Extended-Release Capsules	120	35.8	35.9
Cefepime	16	35.2	35.3
Piperacillin Sodium,Tazobactam Sodium	26	31.4	31.4
Cefepime Hydrochloride	16	31.3	31.4
Vancomycin	54	31.2	31.3
Tacrolimus	127	30.6	30.6
Ampicillin	8	30.1	30.2
Ampicillin Sodium	8	30.1	30.2
Amikacin	16	29.6	29.6
Azacitidine For	17	29.5	29.6
Azacitidine	26	28.1	28.1
Mycophenolate Mofetil	105	28.0	28.1
Mycophenolate Mofetil Hydrochloride	105	28.0	28.0
Vancomycin Hydrochloride	54	27.4	27.4
Melphalan Hydrochloride	21	26.6	26.6
Melphalan	19	26.5	26.5
Piperacillin Sodium And Tazobactam Sodium	16	25.7	25.8
Cyclophosphamide Injection, Solution	116	24.2	24.2
Cyclophosphamide	116	24.2	24.2
Cyclophosphamide For Injection	116	24.2	24.2
Filgrastim	28	23.9	23.9
Anti-Thymocyte Globulin (Rabbit)	6	23.1	23.1
Etoposide	50	22.6	22.6
Tobramycin Solution	8	20.8	20.8
Levofloxacin	38	20.5	20.5
Levofloxacin In 5% Dextrose	38	20.5	20.5
Tobramycin Sulfate	8	20.1	20.2
Vincristine Sulfate	17	18.3	18.3
Venetoclax	23	11.9	11.9
Ruxolitinib	24	10.7	10.7
Dasatinib	11	9.3	9.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.